New Results From One Of The World's Largest Breast Cancer Trials Offer Hope To Thousands Of Women
LONDON, December 14 /PRNewswire/ -- - The Benefits of Anastrozole (Arimidex(R)) Over Tamoxifen at Preventing Breast Cancer Recurrence Improve Over Time - Up to Four Years After Treatment Ends New data from ATAC(x), one of the world's largest and longest-running studies in postmenopausal women with hormone receptor positive (HR+), early breast cance
Source: science20.com